<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530916</url>
  </required_header>
  <id_info>
    <org_study_id>WB2020</org_study_id>
    <nct_id>NCT04530916</nct_id>
  </id_info>
  <brief_title>Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men</brief_title>
  <official_title>Antihypertensive and Vascular-protective Effects of Wild Blueberries in Middle-aged/Older Men.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colorado State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wild Blueberry Association of North America</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Colorado State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Aging&#xD;
      is the primary risk factor for CVD, in large part due to adverse modifications to the&#xD;
      arteries. These modifications include vascular endothelial dysfunction and arterial&#xD;
      stiffness. Vascular endothelial dysfunction is an initiating step in atherosclerosis, and is&#xD;
      primarily caused by reduced nitric oxide (NO) bioavailability secondary to excessive&#xD;
      superoxide-driven oxidative stress and inflammation. Endothelial dysfunction leads to&#xD;
      arterial stiffness and the development of hypertension (HTN) which further increases CVD.&#xD;
      Greater than 2/3 of the US population has elevated blood pressure or stage 1-HTN. As such,&#xD;
      interventions that improve vascular endothelial dysfunction by increasing NO bioavailability&#xD;
      and mitigating excessive oxidative stress and inflammation are needed. Blueberries are rich&#xD;
      in bioactive compounds including flavonoids, phenolic acids, and pterostilbene. These&#xD;
      compounds and their metabolites have been shown to attenuate oxidative stress and&#xD;
      inflammation. The primary goal of this study is to assess the efficacy of blueberries to&#xD;
      improve reduce blood pressure and improve vascular endothelial dysfunction and arterial&#xD;
      stiffness in middle-aged/older men with elevated blood pressure or stage 1-HTN, and baseline&#xD;
      endothelial dysfunction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Brachial and Aortic blood pressure (systolic blood pressure, diastolic blood pressure, pulse pressure, aortic pressure) assessed using an automated blood pressure monitor (SphygmoCor)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reactive hyperemia index</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Endothelial function assessed as reactive hyperemia index using peripheral arterial tonometry (EndoPat)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Augmentation index</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Arterial stiffness assessed as augmentation index using an automated blood pressure monitor (SphygmoCor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Arterial stiffness assessed as carotid-femoral pulse wave velocity using an automated blood pressure monitor (SphygmoCor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell protein expression</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Protein expression will be assessed as an exploratory analysis for markers of nitric oxide bioavailability, inflammation, and/or oxidative stress will be measured by quantitative immunofluorescence in biopsied venous endothelial cells</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Blood hemoglobin A1C will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Blood lipid profiles will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nitric oxide metabolites</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Blood nitrate/nitrite will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICAM-1</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Blood ICAM-1 will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VCAM-1</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Blood VCAM-1 will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral blood mononuclear cell inflammation and oxidative stress</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Exploratory measures analyzed by gene expression analyses</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Hypertension</condition>
  <condition>Aging</condition>
  <condition>Endothelial Dysfunction</condition>
  <condition>Men</condition>
  <arm_group>
    <arm_group_label>Blueberry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>22 g blueberry powder per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>22 g placebo control powder per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Blueberry Powder</intervention_name>
    <description>22 g/day wild blueberry powder</description>
    <arm_group_label>Blueberry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Powder</intervention_name>
    <description>22 g/day placebo powder</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men&#xD;
&#xD;
          -  Aged 45-70 years&#xD;
&#xD;
          -  Elevated blood pressure or stage 1-Hypertension&#xD;
&#xD;
          -  Reactive hyperemia index &lt; 1.67%&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Blood Pressure &lt; 120 (systolic BP) or ≥ 140/90 mm Hg&#xD;
&#xD;
          -  Taking &gt; 1 antihypertensive medication, taking 1 antihypertensive medication more than&#xD;
             1 time per day, and/or taking the antihypertensive medication for &lt; 3 months&#xD;
&#xD;
          -  Diagnosed cancer, cardiovascular disease, diabetes, or gastrointestinal, kidney,&#xD;
             liver, lung, and/or pancreatic disease&#xD;
&#xD;
          -  Triglycerides &gt; 350 mg/dL, low-density lipoprotein cholesterol (LDL-C) ≥ 190 mg/dL,&#xD;
             and/or taking a lipid-lowering medication&#xD;
&#xD;
          -  Testosterone replacement therapy use 6 months prior to study start&#xD;
&#xD;
          -  Weight change ≥ 3 kg in the past 3 months, actively trying to lose weight, or&#xD;
             unwilling to remain weight stable throughout the study&#xD;
&#xD;
          -  Current smokers or history of smoking in the past 12 months&#xD;
&#xD;
          -  Heavy drinkers (&gt; 14 alcoholic drinks/week)&#xD;
&#xD;
          -  Body mass index &lt; 18.5 or &gt; 40 kg/m2&#xD;
&#xD;
          -  Active infection or antibiotic therapy&#xD;
&#xD;
          -  Allergies or contraindication to study treatments or procedures&#xD;
&#xD;
          -  Unable to abstain from taking blood pressure medication for 24 hours prior to test&#xD;
             visits&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sarah A Johnson, PhD, RDN</last_name>
    <phone>970-491-3807</phone>
    <email>sarah.johnson@colostate.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Food and Nutrition Clinical Research Laboratory</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80523-1571</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah A Johnson, PhD, RDN</last_name>
      <phone>970-491-3807</phone>
      <email>sarah.johnson@colostate.edu</email>
    </contact>
    <investigator>
      <last_name>Sarah A Johnson, PhD, RDN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, Arjmandi BH. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015 Mar;115(3):369-377. doi: 10.1016/j.jand.2014.11.001. Epub 2015 Jan 8.</citation>
    <PMID>25578927</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 27, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>May 9, 2021</last_update_submitted>
  <last_update_submitted_qc>May 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Disease</keyword>
  <keyword>Blueberries</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Vascular Dysfunction</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Aging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

